Inner Mongolia Furui Med Sci (300049) - Total Assets

Latest as of March 2026: CN¥3.42 Billion CNY ≈ $500.54 Million USD

Based on the latest financial reports, Inner Mongolia Furui Med Sci (300049) holds total assets worth CN¥3.42 Billion CNY (≈ $500.54 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore cash flow to debt ratio of Inner Mongolia Furui Med Sci to assess how comfortably operating cash covers total debt obligations.

Inner Mongolia Furui Med Sci - Total Assets Trend (2006–2025)

This chart illustrates how Inner Mongolia Furui Med Sci's total assets have evolved over time, based on quarterly financial data. See 300049 net asset value for net asset value and shareholders' equity analysis.

Inner Mongolia Furui Med Sci - Asset Composition Analysis

Current Asset Composition (December 2025)

Inner Mongolia Furui Med Sci's total assets of CN¥3.42 Billion consist of 44.9% current assets and 55.1% non-current assets.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	18.9%
Accounts Receivable	CN¥581.99 Million	16.9%
Inventory	CN¥148.97 Million	4.3%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥583.23 Million	17.0%
Goodwill	CN¥179.50 Million	5.2%

Asset Composition Trend (2006–2025)

This chart illustrates how Inner Mongolia Furui Med Sci's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Inner Mongolia Furui Med Sci (300049) market capitalisation.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Inner Mongolia Furui Med Sci's current assets represent 44.9% of total assets in 2025, a decrease from 47.6% in 2006.
Cash Position: Cash and equivalents constituted 18.9% of total assets in 2025, up from 17.1% in 2006.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 21.0% of total assets, an increase from 10.0% in 2006.
Asset Diversification: The largest asset category is intangible assets at 17.0% of total assets.

Inner Mongolia Furui Med Sci Competitors by Total Assets

Key competitors of Inner Mongolia Furui Med Sci based on total assets are shown below.

Company	Country	Total Assets
Tubize-Fin BR:TUB	Belgium	€1.93 Billion
Verona Pharma plc F:I9SA	Germany	€572.87 Million
Xiamen Amoytop Biotech Co Ltd SHG:688278	China	CN¥3.21 Billion
Syndax Pharmaceuticals Inc NASDAQ:SNDX	USA	$472.67 Million
Neuren Pharmaceuticals Ltd AU:NEU	Australia	AU$331.25 Million
Vor Biopharma Inc NASDAQ:VOR	USA	$506.75 Million
Chengdu Kanghua Biological Products SHE:300841	China	CN¥3.94 Billion
Jiangsu Aidea Pharmaceutical Co Ltd SHG:688488	China	CN¥1.84 Billion

Inner Mongolia Furui Med Sci - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	3.44	4.56	3.97
Quick Ratio	3.10	4.14	3.55
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥1.08 Billion	CN¥1.19 Billion	CN¥823.26 Million

Inner Mongolia Furui Med Sci - Advanced Valuation Insights

This section examines the relationship between Inner Mongolia Furui Med Sci's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	5.55
Latest Market Cap to Assets Ratio	0.53
Asset Growth Rate (YoY)	12.4%
Total Assets	CN¥3.44 Billion
Market Capitalization	$1.83 Billion USD

Valuation Analysis

Below Book Valuation: The market values Inner Mongolia Furui Med Sci's assets below their book value (0.53x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Inner Mongolia Furui Med Sci's assets grew by 12.4% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Inner Mongolia Furui Med Sci (2006–2025)

The table below shows the annual total assets of Inner Mongolia Furui Med Sci from 2006 to 2025.

Year	Total Assets	Change
2025-12-31	CN¥3.44 Billion ≈ $503.22 Million	+12.42%
2024-12-31	CN¥3.06 Billion ≈ $447.61 Million	+15.54%
2023-12-31	CN¥2.65 Billion ≈ $387.41 Million	+4.93%
2022-12-31	CN¥2.52 Billion ≈ $369.21 Million	-0.06%
2021-12-31	CN¥2.52 Billion ≈ $369.43 Million	+10.22%
2020-12-31	CN¥2.29 Billion ≈ $335.18 Million	+1.79%
2019-12-31	CN¥2.25 Billion ≈ $329.28 Million	+5.33%
2018-12-31	CN¥2.14 Billion ≈ $312.62 Million	-14.90%
2017-12-31	CN¥2.51 Billion ≈ $367.37 Million	+4.32%
2016-12-31	CN¥2.41 Billion ≈ $352.17 Million	+17.92%
2015-12-31	CN¥2.04 Billion ≈ $298.65 Million	+53.32%
2014-12-31	CN¥1.33 Billion ≈ $194.80 Million	+16.59%
2013-12-31	CN¥1.14 Billion ≈ $167.08 Million	+23.09%
2012-12-31	CN¥927.58 Million ≈ $135.73 Million	+6.20%
2011-12-31	CN¥873.44 Million ≈ $127.81 Million	+9.78%
2010-12-31	CN¥795.66 Million ≈ $116.43 Million	+217.04%
2009-12-31	CN¥250.96 Million ≈ $36.72 Million	+12.49%
2008-12-31	CN¥223.10 Million ≈ $32.65 Million	+11.03%
2007-12-31	CN¥200.93 Million ≈ $29.40 Million	+6.99%
2006-12-31	CN¥187.80 Million ≈ $27.48 Million	--

About Inner Mongolia Furui Med Sci

SHE:300049 China Biotechnology

Market Cap

$1.83 Billion

CN¥12.47 Billion CNY

Market Cap Rank

#6409 Global

#1270 in China

Share Price

CN¥47.25

Change (1 day)

+4.12%

52-Week Range

CN¥37.14 - CN¥87.87

All Time High

CN¥87.87